Artivion
Stock
Stock
Ticker: AORT
AORT
Price
Price
CHART BY
Frequently asked questions
What is Artivion's market capitalization?
The market capitalization of Artivion is $1.12B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Artivion?
Artivion's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.0675. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Artivion's stock?
Currently, 9 analysts cover Artivion's stock, with a consensus target price of $40.91. Analyst ratings provide insights into the stock's expected performance.
What is Artivion's revenue over the trailing twelve months?
Over the trailing twelve months, Artivion reported a revenue of $471.47M.
What is the EBITDA for Artivion?
Artivion's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $55.80M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Artivion?
Artivion has a free cash flow of -$9.16M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Artivion have, and what sector and industry does it belong to?
Artivion employs approximately 1,800 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Artivion's shares?
The free float of Artivion is 46.16M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $1.12B
- EPS (TTM)
- -$0.0675
- Free Float
- 46.16M
- Revenue (TTM)
- $471.47M
- EBITDA (TTM)
- $55.80M
- Free Cashflow (TTM)
- -$9.16M
Pricing
- 1D span
- $22.73$24.13
- 52W span
- $19.49$48.19
Analyst Ratings
The price target is $40.91 and the stock is covered by 9 analysts.
Buy
9
Hold
0
Sell
0
Information
Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes aortic stents and stent grafts, surgical sealants, and On-X products. The Preservation Services segment offers cardiac and vascular tissue preservation services. The company was founded on January 19, 1984, and is headquartered in Kennesaw, GA.
- Employees
- 1,800
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- Primary Ticker
- AORT
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet